Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Healthy.io Announces Collaboration with Boehringer Ingelheim to Increase Access to Testing for Kidney Disease
Healthy.io, the global leader in transforming the smartphone camera into a medical device, today announced […]
Interius BioTherapeutics Announces Successful Manufacturing Partnership with WuXi Advanced Therapies
Interius BioTherapeutics, a preclinical stage gene therapy company developing novel methods for in vivo cell-specific […]
Life Biosciences and Forge Biologics Announce cGMP Manufacturing Partnership to Advance Development of Novel Gene Therapies for Aging-Related Diseases
Life Biosciences (“Life Bio”), a biotechnology company advancing innovative cellular rejuvenation technologies to reverse diseases […]
Neuro3 Therapeutics Acquires Exclusive Worldwide Rights to Develop and Commercialize Clinical Stage KCNQ2 Activators from Lundbeck
Neuro3 Therapeutics (Neuro3), a biotechnology company focused on the discovery and development of innovative medicines […]
Eisai Enters Into Joint Development Agreement with Blissbio for Antibody Drug Conjugate BB-1701
Eisai announced today that it has entered into a joint development agreement with Bliss Biopharmaceutical […]
Sunovion and Otsuka Initiate Clinical Development of Ulotaront for the Treatment of Generalized Anxiety Disorder
Sunovion Pharmaceuticals and Otsuka Pharmaceutical Development & Commercialization today announced that the first patient has […]
Sable Therapeutics Announces Licensing Agreement with Shanghai Liuqiang Medical Technology
Sable Therapeutics, an early-stage biotechnology company developing novel therapies for fat reduction, today announced that […]
Aldena Therapeutics and Empa Awarded InnoSuisse Funding to Advance STAR Particles as a Novel Drug Delivery Technology for Dermatology
Aldena Therapeutics, a private biotech company pioneering siRNA-based therapies for dermatological indications, and Empa, the […]
Huma and UCB to Provide Digital Health Solution for Myasthenia Gravis
Huma Therapeutics, a leading global digital health company, and UCB, a global biopharmaceutical company, are […]
I-Mab Announces Positive Outcome in Arbitration Relating to Agreements with Tracon
I-Mab, a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more